EGFR activating mutations and their association with response to platinum-doublet chemotherapy in Brazilian non-small cell lung cancer patients. [electronic resource]
Producer: 20150904Description: 389-94 p. digitalISSN:- 1776-260X
- Adenocarcinoma -- genetics
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Brazil
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Cohort Studies
- ErbB Receptors -- genetics
- Exons
- Female
- Gene Deletion
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Paclitaxel -- administration & dosage
- Protein Kinase Inhibitors -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.